Your browser doesn't support javascript.
SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China.
Zhou, Lijun; Li, Cheng; Yang, Huiping; Yuan, Heng; Pan, Ming; Cheng, Xiuwei; Xiao, Chongkun; Su, Xiaoyan; Zhu, Yuanfang; Xu, Jianan; Tang, Jianxiang; Du, Xunbo; Peng, Huanwen; Chen, Xiao; Huang, Tao; Liao, Hongxiu; Xian, Deqiang; Wang, HaoZhou; Liu, Wenwu; Zhou, Ping; Zhang, Zhengdong; Liu, Juan; Wu, Xianping; Zhang, Tao.
  • Zhou L; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Li C; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, China.
  • Yang H; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Yuan H; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Pan M; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Cheng X; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Xiao C; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Su X; Lu County Center for Disease Control and Prevention, Luzhou, China.
  • Zhu Y; Gulin County Center for Disease Control and Prevention, Luzhou, China.
  • Xu J; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Tang J; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, China.
  • Du X; Chengdu Center for Disease Control and Prevention, Chengdu, China.
  • Peng H; Dazhou Center for Disease Control and Prevention, Dazhou, China.
  • Chen X; Nanchong Center for Disease Control and Prevention, Nanchong, China.
  • Huang T; Guangan Center for Disease Control and Prevention, Guangan, China.
  • Liao H; Panzhihua Center for Disease Control and Prevention, Panzhihua, China.
  • Xian D; Luzhou Center for Disease Control and Prevention, Luzhou, China.
  • Wang H; Mianyang Center for Disease Control and Prevention, Mianyang, China.
  • Liu W; Suining Center for Disease Control and Prevention, Suining, China.
  • Zhou P; Yibin Center for Disease Control and Prevention, Yibin, China.
  • Zhang Z; Zigong Center for Disease Control and Prevention, Zigong, China.
  • Liu J; Neijiang Center for Disease Control and Prevention, Neijiang, China.
  • Wu X; Sichuan Center for Disease Control and Prevention, Chengdu, China.
  • Zhang T; Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Sichuan, China.
Front Public Health ; 9: 716483, 2021.
Article in English | MEDLINE | ID: covidwho-1515550
ABSTRACT

Objectives:

To explore and understand the SARS-CoV-2 seroprevalence of convalescents, the association between antibody levels and demographic factors, and the seroepidemiology of convalescents of COVID-19 till March 2021.

Methods:

We recruited 517 voluntary COVID-19 convalescents in Sichuan Province and collected 1,707 serum samples till March 2021. Then we reported the seroprevalence and analyzed the associated factors.

Results:

Recent travel history was associated with IgM levels. Convalescents who had recent travel history were less likely to be IgM antibody negative [OR = 0.232, 95% CI (0.128, 0.420)]. Asymptomatic cases had, approximately, twice the odds of being IgM antibody negative compared with symptomatic cases [OR = 2.583, 95% CI (1.554, 4.293)]. Participants without symptoms were less likely to be IgG seronegative than those with symptoms [OR = 0.511, 95% CI (0.293, 0.891)]. Convalescents aged 40-59 were less likely to be IgG seronegative than those aged below 20 [OR = 0.364, 95% CI (0.138, 0.959)]. The duration of positive IgM antibodies persisted 365 days while the IgG persisted more than 399 days.

Conclusions:

Our findings suggested that recent travel history might be associated with the antibody levels of IgM, while age could be associated with the antibody levels of IgG. Infection type could be associated with both antibody levels of IgM and IgG that declined quicker in asymptomatic cases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.716483

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.716483